Boundless Bio, Inc. Common Stock (BOLD)

USD 1.28

(-1.92%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2018 2017 2016
Revenue - - - - - -
Cost of Revenue 957 Thousand 942 Thousand 682 Thousand - - -
Gross Profit -957 Thousand -942 Thousand -682 Thousand - - -
Operating Expenses 54.79 Million 46.46 Million 25.3 Million 134.37 Million 93.17 Million 60.04 Million
Selling, General and Administrative Expenses 12.15 Million 9.31 Million 6.02 Million 30 Million 17.27 Million 11.27 Million
Research and Development Expenses 41.68 Million 37.15 Million 19.27 Million 104.37 Million 75.9 Million 48.77 Million
Other Expenses - -100 Thousand -5000.00 - - -
Cost and Expenses 54.79 Million 46.46 Million 25.3 Million 134.37 Million 93.17 Million 60.04 Million
Operating Income -54.79 Million -46.46 Million -25.3 Million -134.37 Million -93.17 Million -60.04 Million
Interest Expense - - - - - -
Income Tax Expense - -668 Thousand -96 Thousand 5.55 Million -2.24 Million 378 Thousand
Earnings before Tax -49.43 Million -45.9 Million -25.21 Million -128.82 Million -92.48 Million -59.66 Million
Net Income -49.43 Million -45.9 Million -25.21 Million -128.82 Million -90.23 Million -59.66 Million
Earnings Per Share Basic -2.22 -2.06 -1.13 -2.93 -2.05 -1.36
Earnings Per Share Diluted -2.22 -2.06 -1.13 -2.93 -3.40 -5.59
Weighted Average Shares Outstanding 22.23 Million 22.23 Million 22.23 Million 44.02 Million 44.02 Million 44.02 Million
Weighted Average Shares Outstanding (Diluted) 22.23 Million 22.23 Million 22.23 Million 44.02 Million 26.57 Million 10.67 Million
Gross Margin - - - - - -
EBIT Margin - - - - - -
Profit Margin - - - - - -
EBITDA -48.47 Million -45.52 Million -24.61 Million -121.36 Million -88.73 Million -58.08 Million
Earnings Before Tax Margin - - - - - -

Income Statement Charts